Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3903844
Max Phase: Preclinical
Molecular Formula: C18H20N2O
Molecular Weight: 280.37
Molecule Type: Small molecule
Associated Items:
ID: ALA3903844
Max Phase: Preclinical
Molecular Formula: C18H20N2O
Molecular Weight: 280.37
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CC1(c2ccc(NC(=O)c3ccccc3)cc2)CCNC1
Standard InChI: InChI=1S/C18H20N2O/c1-18(11-12-19-13-18)15-7-9-16(10-8-15)20-17(21)14-5-3-2-4-6-14/h2-10,19H,11-13H2,1H3,(H,20,21)
Standard InChI Key: ORZAKNIXVRBZPG-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 280.37 | Molecular Weight (Monoisotopic): 280.1576 | AlogP: 3.19 | #Rotatable Bonds: 3 |
Polar Surface Area: 41.13 | Molecular Species: BASE | HBA: 2 | HBD: 2 |
#RO5 Violations: 0 | HBA (Lipinski): 3 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: 10.83 | CX LogP: 3.18 | CX LogD: 0.16 |
Aromatic Rings: 2 | Heavy Atoms: 21 | QED Weighted: 0.91 | Np Likeness Score: -0.42 |
1. (2016) Substituted benzamides, |
Source(1):